Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma
NCT01261728Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Dec 2010
- Primary completion
- Aug 2025
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, Cisplatin micelle injection (HA132) in urothelial carcinoma (UC), sponsored by Memorial Sloan Kettering Cancer Center. Started Dec 2010; status: completed.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT01261728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01261728.